|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q59705786
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241121000119.0 |
|
008
|
|
|
241121nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q59705786
|
|
024
|
|
|
‡a
0000-0001-7358-8544
‡2
orcid
|
|
024
|
|
|
‡a
0000-0002-1186-0917
‡2
orcid
|
|
035
|
|
|
‡a
(OCoLC)Q59705786
|
|
100
|
0 |
|
‡a
Seung Hwan Lee
‡c
researcher ORCID ID = 0000-0001-7358-8544
‡9
en
|
|
670
|
|
|
‡a
Author's Addition of N-terminal pro-B-type natriuretic peptide levels to electrocardiography criteria for detection of left ventricular hypertrophy: the ARIRANG study.
|
|
670
|
|
|
‡a
Author's An EEG-based real-time cortical rhythmic activity monitoring system.
|
|
670
|
|
|
‡a
Author's Are clinically insignificant prostate cancers really insignificant among Korean men?
|
|
670
|
|
|
‡a
Author's Association between the neutrophil-to-lymphocyte ratio and intravesical prostatic protrusion in men with benign prostatic hyperplasia
|
|
670
|
|
|
‡a
Author's Association between urinary hesitancy symptoms and uroflowmetry measured urinary hesitancy time in men with lower urinary tract symptoms
|
|
670
|
|
|
‡a
Author's Cancer-Specific Mortality Among Korean Men with Localized or Locally Advanced Prostate Cancer Treated with Radical Prostatectomy Versus Radiotherapy: A Multi-Center Study Using Propensity Scoring and Competing Risk Regression Analyses
|
|
670
|
|
|
‡a
Author's Clinical Efficacy and Safety of Naftopidil Treatment for Patients with Benign Prostatic Hyperplasia and Hypertension: A Prospective, Open-Label Study
|
|
670
|
|
|
‡a
Author's Comparative rapid onset of efficacy between doxazosin gastrointestinal therapeutic system and tamsulosin in patients with lower urinary tract symptoms from benign prostatic hyperplasia: a multicentre, prospective, randomised study.
|
|
670
|
|
|
‡a
Author's Comparison of the response to treatment between Asian and Caucasian men with benign prostatic hyperplasia: long-term results from the combination of dutasteride and tamsulosin study.
|
|
670
|
|
|
‡a
Author's Current status of active surveillance in prostate cancer
|
|
670
|
|
|
‡a
Author's Does performance of robot‐assisted laparoscopic radical prostatectomy within 2 weeks of prostate biopsy affect the outcome?
|
|
670
|
|
|
‡a
Author's Effects of α-blocker 'add on' treatment on blood pressure in symptomatic BPH with or without concomitant hypertension.
|
|
670
|
|
|
‡a
Author's Enzalutamide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: A retrospective Korean multicenter study in a real-world setting
|
|
670
|
|
|
‡a
Author's Feasibility of robot-assisted radical prostatectomy for very-high risk prostate cancer: surgical and oncological outcomes in men aged ≥70 years
|
|
670
|
|
|
‡a
Author's Guideline-directed therapy at discharge in patients with heart failure and atrial fibrillation
|
|
670
|
|
|
‡a
Author's Incidentally detected inguinoscrotal bladder hernia
|
|
670
|
|
|
‡a
Author's Incidentally discovered inverted papilloma of the urinary bladder in patients with lower urinary tract symptoms.
|
|
670
|
|
|
‡a
Author's Inherent characteristics of metachronous metastatic renal cell carcinoma in the era of targeted agents
|
|
670
|
|
|
‡a
Author's Korean urologist's view of practice patterns in diagnosis and management of benign prostatic hyperplasia: a nationwide survey.
|
|
670
|
|
|
‡a
Author's Pathological Characteristics of Prostate Cancer in Men Aged < 50 Years Treated with Radical Prostatectomy: a Multi-Centre Study in Korea
|
|
670
|
|
|
‡a
Author's Predicting Insignificant Prostate Cancer: Analysis of the Pathological Outcomes of Candidates for Active Surveillance according to the Pre-International Society of Urological Pathology (Pre-ISUP) 2014 Era Versus the Post-ISUP2014 Era
|
|
670
|
|
|
‡a
Author's Prognostic Effect of Guideline-Directed Therapy Is More Noticeable Early in the Course of Heart Failure
|
|
670
|
|
|
‡a
Author's Renal abscesses measuring 5 cm or less: outcome of medical treatment without therapeutic drainage.
|
|
670
|
|
|
‡a
Author's Safety and Efficacy of a New Ultrathin Sirolimus-Eluting Stent with Abluminal Biodegradable Polymer in Real-World Practice
|
|
670
|
|
|
‡a
Author's Stone heterogeneity index on single-energy noncontrast computed tomography can be a positive predictor of urinary stone composition.
|
|
670
|
|
|
‡a
Author's The Association of A Number of Predictive Factors for The Recurrence of Papillary Urothelial Neoplasm of Low Malignant Potential: Prognostic Analysis From Multiple Academic Centers
|
|
670
|
|
|
‡a
Author's The effects of long-term androgen deprivation therapy on penile length in patients with prostate cancer: a single-center, prospective, open-label, observational study.
|
|
670
|
|
|
‡a
Author's The effects of the period between biopsy and diffusion-weighted magnetic resonance imaging on cancer staging in localized prostate cancer.
|
|
909
|
|
|
‡a
(orcid) 0000000211860917
‡9
1
|
|
909
|
|
|
‡a
(orcid) 0000000173588544
‡9
1
|
|
919
|
|
|
‡a
prognosticeffectofguidelinedirectedtherapyismorenoticeableearlyinthecourseofheartfailure
‡A
Prognostic Effect of Guideline-Directed Therapy Is More Noticeable Early in the Course of Heart Failure
‡9
1
|
|
919
|
|
|
‡a
renalabscessesmeasuring5900orlessoutcomeofmedicaltreatmentwithouttherapeuticdrainage
‡A
Renal abscesses measuring 5 cm or less: outcome of medical treatment without therapeutic drainage.
‡9
1
|
|
919
|
|
|
‡a
safetyandefficacyofanewultrathinsirolimuselutingstentwithabluminalbiodegradablepolymerinrealworldpractice
‡A
Safety and Efficacy of a New Ultrathin Sirolimus-Eluting Stent with Abluminal Biodegradable Polymer in Real-World Practice
‡9
1
|
|
919
|
|
|
‡a
stoneheterogeneityindexonsingleenergynoncontrastcomputedtomographycanbeapositivepredictorofurinarystonecomposition
‡A
Stone heterogeneity index on single-energy noncontrast computed tomography can be a positive predictor of urinary stone composition.
‡9
1
|
|
919
|
|
|
‡a
associationofanumberofpredictivefactorsfortherecurrenceofpapillaryurothelialneoplasmoflowmalignantpotentialprognosticanalysisfrommultipleacademiccenters
‡A
The Association of A Number of Predictive Factors for The Recurrence of Papillary Urothelial Neoplasm of Low Malignant Potential: Prognostic Analysis From Multiple Academic Centers
‡9
1
|
|
919
|
|
|
‡a
effectsoflongtermandrogendeprivationtherapyonpenilelengthinpatientswithprostatecancerasinglecenterprospectiveopenlabelobservationalstudy
‡A
The effects of long-term androgen deprivation therapy on penile length in patients with prostate cancer: a single-center, prospective, open-label, observational study.
‡9
1
|
|
919
|
|
|
‡a
effectsoftheperiodbetweenbiopsyanddiffusionweightedmagneticresonanceimagingoncancerstaginginlocalizedprostatecancer
‡A
The effects of the period between biopsy and diffusion-weighted magnetic resonance imaging on cancer staging in localized prostate cancer.
‡9
1
|
|
919
|
|
|
‡a
pathologicalcharacteristicsofprostatecancerinmenaged50yearstreatedwithradicalprostatectomyamulticentrestudyinkorea
‡A
Pathological Characteristics of Prostate Cancer in Men Aged < 50 Years Treated with Radical Prostatectomy: a Multi-Centre Study in Korea
‡9
1
|
|
919
|
|
|
‡a
koreanurologistsviewofpracticepatternsindiagnosisandmanagementofbenignprostatichyperplasiaanationwidesurvey
‡A
Korean urologist's view of practice patterns in diagnosis and management of benign prostatic hyperplasia: a nationwide survey.
‡9
1
|
|
919
|
|
|
‡a
inherentcharacteristicsofmetachronousmetastaticrenalcellcarcinomaintheeraoftargetedagents
‡A
Inherent characteristics of metachronous metastatic renal cell carcinoma in the era of targeted agents
‡9
1
|
|
919
|
|
|
‡a
incidentallydiscoveredinvertedpapillomaoftheurinarybladderinpatientswithlowerurinarytractsymptoms
‡A
Incidentally discovered inverted papilloma of the urinary bladder in patients with lower urinary tract symptoms.
‡9
1
|
|
919
|
|
|
‡a
incidentallydetectedinguinoscrotalbladderhernia
‡A
Incidentally detected inguinoscrotal bladder hernia
‡9
1
|
|
919
|
|
|
‡a
guidelinedirectedtherapyatdischargeinpatientswithheartfailureandatrialfibrillation
‡A
Guideline-directed therapy at discharge in patients with heart failure and atrial fibrillation
‡9
1
|
|
919
|
|
|
‡a
feasibilityofrobotassistedradicalprostatectomyforveryhighriskprostatecancersurgicalandoncologicaloutcomesinmenaged70years
‡A
Feasibility of robot-assisted radical prostatectomy for very-high risk prostate cancer: surgical and oncological outcomes in men aged ≥70 years
‡9
1
|
|
919
|
|
|
‡a
enzalutamideinchemotherapynaivepatientswithmetastaticcastrationresistantprostatecanceraretrospectivekoreanmulticenterstudyinarealworldsetting
‡A
Enzalutamide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: A retrospective Korean multicenter study in a real-world setting
‡9
1
|
|
919
|
|
|
‡a
effectsofαblockeraddontreatmentonbloodpressureinsymptomaticbphwithorwithoutconcomitanthypertension
‡A
Effects of α-blocker 'add on' treatment on blood pressure in symptomatic BPH with or without concomitant hypertension.
‡9
1
|
|
919
|
|
|
‡a
doesperformanceofrobotassistedlaparoscopicradicalprostatectomywithin2weeksofprostatebiopsyaffecttheoutcome
‡A
Does performance of robot‐assisted laparoscopic radical prostatectomy within 2 weeks of prostate biopsy affect the outcome?
‡9
1
|
|
919
|
|
|
‡a
currentstatusofactivesurveillanceinprostatecancer
‡A
Current status of active surveillance in prostate cancer
‡9
1
|
|
919
|
|
|
‡a
comparisonoftheresponsetotreatmentbetweenasianandcaucasianmenwithbenignprostatichyperplasialongtermresultsfromthecombinationofdutasterideandtamsulosinstudy
‡A
Comparison of the response to treatment between Asian and Caucasian men with benign prostatic hyperplasia: long-term results from the combination of dutasteride and tamsulosin study.
‡9
1
|
|
919
|
|
|
‡a
comparativerapidonsetofefficacybetweendoxazosingastrointestinaltherapeuticsystemandtamsulosininpatientswithlowerurinarytractsymptomsfrombenignprostatichyperplasiaamulticentreprospectiverandomisedstudy
‡A
Comparative rapid onset of efficacy between doxazosin gastrointestinal therapeutic system and tamsulosin in patients with lower urinary tract symptoms from benign prostatic hyperplasia: a multicentre, prospective, randomised study.
‡9
1
|
|
919
|
|
|
‡a
clinicalefficacyandsafetyofnaftopidiltreatmentforpatientswithbenignprostatichyperplasiaandhypertensionaprospectiveopenlabelstudy
‡A
Clinical Efficacy and Safety of Naftopidil Treatment for Patients with Benign Prostatic Hyperplasia and Hypertension: A Prospective, Open-Label Study
‡9
1
|
|
919
|
|
|
‡a
cancerspecificmortalityamongkoreanmenwithlocalizedorlocallyadvancedprostatecancertreatedwithradicalprostatectomyversusradiotherapyamulticenterstudyusingpropensityscoringandcompetingriskregressionanalyses
‡A
Cancer-Specific Mortality Among Korean Men with Localized or Locally Advanced Prostate Cancer Treated with Radical Prostatectomy Versus Radiotherapy: A Multi-Center Study Using Propensity Scoring and Competing Risk Regression Analyses
‡9
1
|
|
919
|
|
|
‡a
associationbetweenurinaryhesitancysymptomsanduroflowmetrymeasuredurinaryhesitancytimeinmenwithlowerurinarytractsymptoms
‡A
Association between urinary hesitancy symptoms and uroflowmetry measured urinary hesitancy time in men with lower urinary tract symptoms
‡9
1
|
|
919
|
|
|
‡a
associationbetweentheneutrophiltolymphocyteratioandintravesicalprostaticprotrusioninmenwithbenignprostatichyperplasia
‡A
Association between the neutrophil-to-lymphocyte ratio and intravesical prostatic protrusion in men with benign prostatic hyperplasia
‡9
1
|
|
919
|
|
|
‡a
areclinicallyinsignificantprostatecancersreallyinsignificantamongkoreanmen
‡A
Are clinically insignificant prostate cancers really insignificant among Korean men?
‡9
1
|
|
919
|
|
|
‡a
eegbasedrealtimecorticalrhythmicactivitymonitoringsystem
‡A
An EEG-based real-time cortical rhythmic activity monitoring system.
‡9
1
|
|
919
|
|
|
‡a
additionofnterminalprobtypenatriureticpeptidelevelstoelectrocardiographycriteriafordetectionofleftventricularhypertrophythearirangstudy
‡A
Addition of N-terminal pro-B-type natriuretic peptide levels to electrocardiography criteria for detection of left ventricular hypertrophy: the ARIRANG study.
‡9
1
|
|
919
|
|
|
‡a
predictinginsignificantprostatecanceranalysisofthepathologicaloutcomesofcandidatesforactivesurveillanceaccordingtothepreinternationalsocietyofurologicalpathologypreisup2014eraversusthepostisup2014era
‡A
Predicting Insignificant Prostate Cancer: Analysis of the Pathological Outcomes of Candidates for Active Surveillance according to the Pre-International Society of Urological Pathology (Pre-ISUP) 2014 Era Versus the Post-ISUP2014 Era
‡9
1
|
|
996
|
|
|
‡2
ISNI|000000002340202X
|
|
996
|
|
|
‡2
ISNI|0000000467816514
|
|
996
|
|
|
‡2
ISNI|0000000505372038
|
|
996
|
|
|
‡2
DNB|129908398
|
|
996
|
|
|
‡2
ISNI|0000000465029859
|
|
996
|
|
|
‡2
ISNI|0000000514754169
|
|
996
|
|
|
‡2
W2Z|1560508703583
|
|
996
|
|
|
‡2
ISNI|0000000475208957
|
|
996
|
|
|
‡2
ISNI|0000000513374586
|
|
996
|
|
|
‡2
ISNI|0000000493969629
|
|
996
|
|
|
‡2
ISNI|0000000516701394
|
|
996
|
|
|
‡2
ISNI|0000000477803389
|
|
996
|
|
|
‡2
BNF|17942727
|
|
996
|
|
|
‡2
ISNI|0000000473411038
|
|
996
|
|
|
‡2
ISNI|0000000477173604
|
|
996
|
|
|
‡2
DNB|17092291X
|
|
996
|
|
|
‡2
DNB|119198061
|
|
996
|
|
|
‡2
ISNI|0000000507233680
|
|
996
|
|
|
‡2
BIBSYS|1560508703583
|
|
996
|
|
|
‡2
ISNI|0000000468144027
|
|
996
|
|
|
‡2
NKC|jx20130211003
|
|
996
|
|
|
‡2
ISNI|0000000474985308
|
|
996
|
|
|
‡2
ISNI|0000000464369499
|
|
996
|
|
|
‡2
DNB|1197745602
|
|
996
|
|
|
‡2
ISNI|0000000511676513
|
|
996
|
|
|
‡2
ISNI|0000000501810782
|
|
996
|
|
|
‡2
ISNI|0000000478410122
|
|
996
|
|
|
‡2
ISNI|0000000473912254
|
|
996
|
|
|
‡2
ISNI|0000000476623167
|
|
996
|
|
|
‡2
DNB|1089196148
|
|
996
|
|
|
‡2
ISNI|0000000465079821
|
|
996
|
|
|
‡2
ISNI|0000000468144158
|
|
996
|
|
|
‡2
ISNI|0000000479096956
|
|
996
|
|
|
‡2
ISNI|0000000476764592
|
|
996
|
|
|
‡2
ISNI|0000000081882500
|
|
996
|
|
|
‡2
ISNI|0000000464369819
|
|
996
|
|
|
‡2
ISNI|0000000505189970
|
|
996
|
|
|
‡2
ISNI|0000000492334509
|
|
996
|
|
|
‡2
DNB|173856152
|
|
996
|
|
|
‡2
NII|DA15735747
|
|
996
|
|
|
‡2
ISNI|0000000478568034
|
|
996
|
|
|
‡2
NTA|110256859
|
|
996
|
|
|
‡2
ISNI|0000000476434737
|
|
996
|
|
|
‡2
ISNI|0000000464763410
|
|
996
|
|
|
‡2
ISNI|000000046469016X
|
|
996
|
|
|
‡2
ISNI|0000000117725962
|
|
996
|
|
|
‡2
ISNI|0000000493023876
|
|
996
|
|
|
‡2
ISNI|0000000464621359
|
|
996
|
|
|
‡2
DNB|1208017950
|
|
996
|
|
|
‡2
LC|nb2013002329
|
|
996
|
|
|
‡2
ISNI|0000000467671124
|
|
996
|
|
|
‡2
ISNI|0000000514823961
|
|
996
|
|
|
‡2
ISNI|0000000473954323
|
|
996
|
|
|
‡2
ISNI|0000000479445861
|
|
996
|
|
|
‡2
LC|nb2012025603
|
|
996
|
|
|
‡2
ISNI|0000000473770102
|
|
996
|
|
|
‡2
ISNI|000000046509057X
|
|
996
|
|
|
‡2
ISNI|0000000473889808
|
|
996
|
|
|
‡2
ISNI|0000000468568356
|
|
996
|
|
|
‡2
ISNI|0000000513308490
|
|
996
|
|
|
‡2
ISNI|0000000067740346
|
|
996
|
|
|
‡2
ISNI|0000000505920727
|
|
996
|
|
|
‡2
NII|DA1679049X
|
|
996
|
|
|
‡2
ISNI|0000000468044309
|
|
996
|
|
|
‡2
DNB|1151918563
|
|
996
|
|
|
‡2
NII|DA13815674
|
|
996
|
|
|
‡2
ISNI|0000000464779359
|
|
996
|
|
|
‡2
DNB|1067335552
|
|
996
|
|
|
‡2
ISNI|0000000125117983
|
|
996
|
|
|
‡2
DNB|1345227833
|
|
996
|
|
|
‡2
DNB|1011457024
|
|
996
|
|
|
‡2
ISNI|0000000464860237
|
|
996
|
|
|
‡2
ISNI|000000051350343X
|
|
996
|
|
|
‡2
ISNI|0000000473620366
|
|
996
|
|
|
‡2
ISNI|0000000468579717
|
|
996
|
|
|
‡2
PLWABN|9810670398705606
|
|
996
|
|
|
‡2
ISNI|0000000473756028
|
|
996
|
|
|
‡2
ISNI|0000000114530393
|
|
996
|
|
|
‡2
ISNI|0000000513502699
|
|
996
|
|
|
‡2
ISNI|0000000505502541
|
|
996
|
|
|
‡2
NDL|01220406
|
|
996
|
|
|
‡2
ISNI|0000000504225458
|
|
996
|
|
|
‡2
ISNI|0000000505501258
|
|
996
|
|
|
‡2
LC|no2016123233
|
|
996
|
|
|
‡2
ISNI|0000000514711388
|
|
996
|
|
|
‡2
ISNI|0000000480261082
|
|
996
|
|
|
‡2
BIBSYS|90234865
|
|
996
|
|
|
‡2
ISNI|0000000513571328
|
|
996
|
|
|
‡2
LC|nr 96027601
|
|
996
|
|
|
‡2
DNB|1036987175
|
|
996
|
|
|
‡2
ISNI|0000000468047091
|
|
996
|
|
|
‡2
ISNI|0000000513391909
|
|
996
|
|
|
‡2
ISNI|0000000493134250
|
|
996
|
|
|
‡2
ISNI|0000000493086543
|
|
996
|
|
|
‡2
ISNI|0000000492846475
|
|
996
|
|
|
‡2
ISNI|0000000463313960
|
|
996
|
|
|
‡2
ISNI|0000000467813794
|
|
996
|
|
|
‡2
ISNI|0000000493979907
|
|
996
|
|
|
‡2
ISNI|0000000483560053
|
|
996
|
|
|
‡2
ISNI|0000000461044840
|
|
996
|
|
|
‡2
ISNI|0000000464599868
|
|
996
|
|
|
‡2
ISNI|0000000499863120
|
|
996
|
|
|
‡2
ISNI|0000000493134656
|
|
996
|
|
|
‡2
ISNI|0000000513365532
|
|
996
|
|
|
‡2
J9U|987007397794305171
|
|
996
|
|
|
‡2
ISNI|0000000492317215
|
|
996
|
|
|
‡2
ISNI|0000000505337574
|
|
996
|
|
|
‡2
ISNI|0000000475171250
|
|
996
|
|
|
‡2
ISNI|000000000179099X
|
|
996
|
|
|
‡2
ISNI|0000000467786335
|
|
996
|
|
|
‡2
ISNI|0000000029879363
|
|
996
|
|
|
‡2
ISNI|0000000505534658
|
|
996
|
|
|
‡2
ISNI|0000000385766533
|
|
996
|
|
|
‡2
ISNI|0000000467815984
|
|
996
|
|
|
‡2
DNB|1035260069
|
|
996
|
|
|
‡2
ISNI|0000000476473138
|
|
996
|
|
|
‡2
ISNI|0000000492460900
|
|
996
|
|
|
‡2
ISNI|0000000474066360
|
|
996
|
|
|
‡2
ISNI|000000049127812X
|
|
996
|
|
|
‡2
ISNI|0000000513374754
|
|
996
|
|
|
‡2
ISNI|0000000505561453
|
|
996
|
|
|
‡2
ISNI|0000000477776093
|
|
996
|
|
|
‡2
ISNI|0000000473764853
|
|
996
|
|
|
‡2
SUDOC|109144198
|
|
996
|
|
|
‡2
ISNI|0000000505152078
|
|
996
|
|
|
‡2
ISNI|0000000493288874
|
|
996
|
|
|
‡2
ISNI|0000000505235631
|
|
996
|
|
|
‡2
SUDOC|104460385
|
|
996
|
|
|
‡2
ISNI|0000000468591281
|
|
996
|
|
|
‡2
LC|nb2009007219
|
|
996
|
|
|
‡2
ISNI|0000000467797018
|
|
996
|
|
|
‡2
ISNI|0000000461086821
|
|
996
|
|
|
‡2
NUKAT|n 2019041985
|
|
996
|
|
|
‡2
ISNI|0000000505847267
|
|
996
|
|
|
‡2
CAOONL|ncf10725195
|
|
996
|
|
|
‡2
ISNI|0000000464891412
|
|
996
|
|
|
‡2
ISNI|0000000514834011
|
|
996
|
|
|
‡2
NII|DA12031089
|
|
996
|
|
|
‡2
ISNI|0000000040812012
|
|
996
|
|
|
‡2
ISNI|0000000480167192
|
|
996
|
|
|
‡2
LC|n 2021037103
|
|
996
|
|
|
‡2
LC|n 2017034874
|
|
996
|
|
|
‡2
ISNI|000000049396983X
|
|
996
|
|
|
‡2
ISNI|0000000477776413
|
|
996
|
|
|
‡2
ISNI|0000000460983520
|
|
996
|
|
|
‡2
ISNI|0000000511075777
|
|
996
|
|
|
‡2
LC|n 2005027677
|
|
996
|
|
|
‡2
NUKAT|n 2008107872
|
|
996
|
|
|
‡2
ISNI|0000000474874392
|
|
996
|
|
|
‡2
ISNI|0000000516689735
|
|
996
|
|
|
‡2
ISNI|0000000480320265
|
|
996
|
|
|
‡2
ISNI|0000000467610647
|
|
996
|
|
|
‡2
DNB|1025238729
|
|
996
|
|
|
‡2
DNB|1232410683
|
|
996
|
|
|
‡2
ISNI|0000000480261859
|
|
996
|
|
|
‡2
ISNI|0000000464887050
|
|
996
|
|
|
‡2
ISNI|0000000464622407
|
|
996
|
|
|
‡2
ISNI|0000000493072627
|
|
996
|
|
|
‡2
ISNI|0000000493086973
|
|
996
|
|
|
‡2
ISNI|0000000467788138
|
|
996
|
|
|
‡2
ISNI|0000000513359570
|
|
996
|
|
|
‡2
ISNI|0000000464428866
|
|
996
|
|
|
‡2
BNF|13626499
|
|
996
|
|
|
‡2
ISNI|0000000505592196
|
|
996
|
|
|
‡2
ISNI|0000000054571328
|
|
996
|
|
|
‡2
LC|no2021130820
|
|
996
|
|
|
‡2
ISNI|0000000468055278
|
|
996
|
|
|
‡2
ISNI|000000048026251X
|
|
996
|
|
|
‡2
LC|no2021105274
|
|
996
|
|
|
‡2
J9U|987007421998605171
|
|
996
|
|
|
‡2
ISNI|0000000468044974
|
|
996
|
|
|
‡2
BNCHL|10000000000000000281361
|
|
996
|
|
|
‡2
LC|no2022015076
|
|
996
|
|
|
‡2
SUDOC|113295855
|
|
996
|
|
|
‡2
ISNI|0000000473711209
|
|
996
|
|
|
‡2
LC|n 2024021886
|
|
996
|
|
|
‡2
LC|no2014123562
|
|
996
|
|
|
‡2
ISNI|0000000480262456
|
|
996
|
|
|
‡2
DNB|1048191168
|
|
996
|
|
|
‡2
LC|no2008093527
|
|
996
|
|
|
‡2
ISNI|0000000514833916
|
|
996
|
|
|
‡2
SUDOC|195022149
|
|
996
|
|
|
‡2
ISNI|0000000044791423
|
|
996
|
|
|
‡2
ISNI|0000000468166373
|
|
996
|
|
|
‡2
ISNI|0000000513563723
|
|
996
|
|
|
‡2
ISNI|0000000512502603
|
|
996
|
|
|
‡2
ISNI|0000000494087628
|
|
996
|
|
|
‡2
ISNI|0000000513588306
|
|
996
|
|
|
‡2
ISNI|0000000074576038
|
|
996
|
|
|
‡2
ISNI|0000000474730794
|
|
996
|
|
|
‡2
LC|nb2019003697
|
|
996
|
|
|
‡2
ISNI|0000000475980920
|
|
996
|
|
|
‡2
ISNI|0000000476622914
|
|
996
|
|
|
‡2
ISNI|0000000477663769
|
|
996
|
|
|
‡2
SUDOC|279471017
|
|
996
|
|
|
‡2
ISNI|0000000464598654
|
|
996
|
|
|
‡2
LC|n 2020014099
|
|
996
|
|
|
‡2
ISNI|000000005279304X
|
|
996
|
|
|
‡2
ISNI|0000000492164669
|
|
996
|
|
|
‡2
ISNI|0000000509580125
|
|
996
|
|
|
‡2
ISNI|0000000492062996
|
|
996
|
|
|
‡2
BNF|16123210
|
|
996
|
|
|
‡2
ISNI|0000000464417841
|
|
996
|
|
|
‡2
ISNI|0000000473764538
|
|
996
|
|
|
‡2
SUDOC|113413033
|
|
996
|
|
|
‡2
ISNI|0000000493992706
|
|
996
|
|
|
‡2
ISNI|0000000480111236
|
|
996
|
|
|
‡2
ISNI|0000000513592970
|
|
996
|
|
|
‡2
DNB|1030161615
|
|
996
|
|
|
‡2
ISNI|0000000479280024
|
|
996
|
|
|
‡2
ISNI|0000000512285397
|
|
996
|
|
|
‡2
ISNI|0000000493207800
|
|
996
|
|
|
‡2
J9U|987007605627505171
|
|
996
|
|
|
‡2
ISNI|0000000468304297
|
|
996
|
|
|
‡2
ISNI|0000000505499039
|
|
996
|
|
|
‡2
ISNI|0000000464269893
|
|
996
|
|
|
‡2
ISNI|0000000513307412
|
|
996
|
|
|
‡2
ISNI|0000000468562712
|
|
996
|
|
|
‡2
DNB|129631477
|
|
996
|
|
|
‡2
ISNI|0000000464203413
|
|
996
|
|
|
‡2
ISNI|0000000468513726
|
|
996
|
|
|
‡2
ISNI|000000046781640X
|
|
996
|
|
|
‡2
ISNI|0000000464816543
|
|
996
|
|
|
‡2
ISNI|0000000514762345
|
|
996
|
|
|
‡2
ISNI|0000000463341574
|
|
996
|
|
|
‡2
ISNI|0000000492205723
|
|
996
|
|
|
‡2
LC|no2016093397
|
|
996
|
|
|
‡2
BNF|18155454
|
|
996
|
|
|
‡2
ISNI|0000000453801514
|
|
996
|
|
|
‡2
ISNI|0000000505078779
|
|
996
|
|
|
‡2
ISNI|0000000493990399
|
|
996
|
|
|
‡2
ISNI|0000000505589499
|
|
996
|
|
|
‡2
ISNI|0000000473886455
|
|
996
|
|
|
‡2
ISNI|0000000505365065
|
|
996
|
|
|
‡2
ISNI|0000000464622423
|
|
996
|
|
|
‡2
ISNI|0000000468604652
|
|
996
|
|
|
‡2
ISNI|000000047377156X
|
|
996
|
|
|
‡2
ISNI|000000050592471X
|
|
996
|
|
|
‡2
ISNI|0000000479098062
|
|
996
|
|
|
‡2
ISNI|0000000463588307
|
|
996
|
|
|
‡2
ISNI|0000000464821078
|
|
996
|
|
|
‡2
ISNI|0000000480118323
|
|
996
|
|
|
‡2
ISNI|0000000465085201
|
|
996
|
|
|
‡2
ISNI|0000000509029026
|
|
996
|
|
|
‡2
LC|n 99804100
|
|
996
|
|
|
‡2
ISNI|0000000493993282
|
|
996
|
|
|
‡2
ISNI|0000000473843543
|
|
996
|
|
|
‡2
ISNI|0000000512298470
|
|
996
|
|
|
‡2
NTA|344683915
|
|
996
|
|
|
‡2
ISNI|0000000513385365
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
